DFNA20/26 and Other ACTG1-Associated Phenotypes: A Case Report and Review of the Literature.
Ugo SorrentinoChiara PiccoloChiara RigonValeria BrassonEva TrevissonFrancesca BoarettoAlessandro MartiniMatteo CassinaPublished in: Audiology research (2021)
Since the early 2000s, an ever-increasing subset of missense pathogenic variants in the ACTG1 gene has been associated with an autosomal-dominant, progressive, typically post-lingual non-syndromic hearing loss (NSHL) condition designed as DFNA20/26. ACTG1 gene encodes gamma actin, the predominant actin protein in the cytoskeleton of auditory hair cells; its normal expression and function are essential for the stereocilia maintenance. Different gain-of-function pathogenic variants of ACTG1 have been associated with two major phenotypes: DFNA20/26 and Baraitser-Winter syndrome, a multiple congenital anomaly disorder. Here, we report a novel ACTG1 variant [c.625G>A (p. Val209Met)] in an adult patient with moderate-severe NSHL characterized by a downsloping audiogram. The patient, who had a clinical history of slowly progressive NSHL and tinnitus, was referred to our laboratory for the analysis of a large panel of NSHL-associated genes by next generation sequencing. An extensive review of previously reported ACTG1 variants and their associated phenotypes was also performed.
Keyphrases
- copy number
- hearing loss
- genome wide
- case report
- multiple sclerosis
- intellectual disability
- induced apoptosis
- dna methylation
- poor prognosis
- binding protein
- genome wide analysis
- early onset
- tyrosine kinase
- gene expression
- oxidative stress
- signaling pathway
- cell migration
- long non coding rna
- protein protein
- bioinformatics analysis